Literature DB >> 12175535

Sphingosine-1-phosphate stimulates human glioma cell proliferation through Gi-coupled receptors: role of ERK MAP kinase and phosphatidylinositol 3-kinase beta.

James Van Brocklyn1, Catherine Letterle, Pamela Snyder, Thomas Prior.   

Abstract

The regulation of glioma cell proliferation by sphingosine-1-phosphate (S1P) was studied using the human glioblastoma cell line U-373 MG. U-373 MG cells responded mitogenically to nanomolar concentrations of S1P, and express mRNA encoding the S1P receptors S1P1/endothelial differentiation gene (EDG)-1, S1P3/EDG-3 and S1P2/EDG-5. S1P-induced proliferation required extracellular signal-regulated kinase activation and was partially sensitive to pertussis toxin and wortmannin, indicating involvement of a Gi-coupled receptor and phosphatidylinositol 3-kinase. Moreover, S1P1, S1P3 and S1P2 receptors are expressed in the majority of human glioblastomas as determined by reverse transcriptase-polymerase chain reaction analysis. Thus, S1P signaling through EDG receptors may contribute to glioblastoma growth in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12175535     DOI: 10.1016/s0304-3835(02)00050-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  39 in total

1.  Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors.

Authors:  Mithun R Raje; Kenneth Knott; Yugesh Kharel; Philippe Bissel; Kevin R Lynch; Webster L Santos
Journal:  Bioorg Med Chem       Date:  2011-11-15       Impact factor: 3.641

2.  Sphingosine-1-phosphate and calcium signaling in cerebellar astrocytes and differentiated granule cells.

Authors:  Paola Giussani; Anita Ferraretto; Claudia Gravaghi; Rosaria Bassi; Guido Tettamanti; Laura Riboni; Paola Viani
Journal:  Neurochem Res       Date:  2006-12-07       Impact factor: 3.996

3.  Resveratrol induces apoptosis of leukemia cell line K562 by modulation of sphingosine kinase-1 pathway.

Authors:  Hongying Tian; Zhongcui Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

4.  Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation.

Authors:  K Alexa Orr Gandy; Mohamad Adada; Daniel Canals; Brittany Carroll; Patrick Roddy; Yusuf A Hannun; Lina M Obeid
Journal:  FASEB J       Date:  2013-04-29       Impact factor: 5.191

5.  A role of sphingosine kinase 1 in head and neck carcinogenesis.

Authors:  Keisuke Shirai; Tatsuya Kaneshiro; Masayuki Wada; Hideki Furuya; Jacek Bielawski; Yusuf A Hannun; Lina M Obeid; Besim Ogretmen; Toshihiko Kawamori
Journal:  Cancer Prev Res (Phila)       Date:  2011-01-05

6.  IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines.

Authors:  Qinglin Liu; Gang Li; Ronghui Li; Jie Shen; Qiaowei He; Lin Deng; Cai Zhang; Jian Zhang
Journal:  J Neurooncol       Date:  2010-04-02       Impact factor: 4.130

7.  Interleukin-1 regulates the expression of sphingosine kinase 1 in glioblastoma cells.

Authors:  Barbara S Paugh; Lauren Bryan; Steven W Paugh; Katarzyna M Wilczynska; Silvina M Alvarez; Sandeep K Singh; Dmitri Kapitonov; Hanna Rokita; Sarah Wright; Irene Griswold-Prenner; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

8.  Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61.

Authors:  Nicholas Young; Dennis K Pearl; James R Van Brocklyn
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

Review 9.  Targeting SphK1 as a new strategy against cancer.

Authors:  Dai Shida; Kazuaki Takabe; Dmitri Kapitonov; Sheldon Milstien; Sarah Spiegel
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

10.  Human neural progenitors express functional lysophospholipid receptors that regulate cell growth and morphology.

Authors:  Jillian H Hurst; Jennifer Mumaw; David W Machacek; Carla Sturkie; Phillip Callihan; Steve L Stice; Shelley B Hooks
Journal:  BMC Neurosci       Date:  2008-12-11       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.